Brief: Incannex Completes Successful Pre-IND Meeting With FDA For CannQuit-N
Feb 16 (Reuters) - Incannex Healthcare Inc IXHL.O :
* INCANNEX COMPLETES SUCCESSFUL PRE-IND MEETING WITH THE FDA
FOR
CANNQUIT-N; A NOVEL SOLUTION FOR TOBACCO SMOKING CESSATION
* INCANNEX HEALTHCARE: FDA REVIEWED CANNQUIT-N MEETING
PACKAGE AND
PROVIDED RECOMMENDATIONS ON KEY DESIGN ASPECTS OF PROPOSED
CLINICAL TRIALS
* INCANNEX HEALTHCARE INC: FDA ALSO CONFIRMED PROPOSED
STRATEGIES
FOR MANUFACTURING AND QUALITY CONTROL ARE APPROPRIATE
Source text for Eikon: ID:nGNX7wXn8V
Further company coverage: IXHL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsIncannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Incannex Healthcare Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Incannex Receives Additional A$5.1 Million Research And Development Tax Incentive Refund
Brief: Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea
Brief: Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position